STOCK TITAN

Cue Health (HLTH) Stock News

HLTH NYSE

Welcome to our dedicated page for Cue Health news (Ticker: HLTH), a resource for investors and traders seeking the latest updates and insights on Cue Health stock.

Cue Health Inc. news covered the company's healthcare technology business, including diagnostic-enabled care, at-home and point-of-care molecular testing, telehealth services, FDA-related product developments, earnings releases, and governance actions. Recurring updates described its COVID-19 and Mpox diagnostic products, customer categories across public agencies and private-sector healthcare users, and cost-reduction or operational efficiency actions.

Later Cue Health news documented the company's Chapter 7 bankruptcy filing and planned wind down, including the intended sale of assets and creditor-payment process under the Bankruptcy Code.

Rhea-AI Summary

Made Scientific (HLTH) appointed Ted Dolan and Soyoung Park to its Board to support scale-up and commercial readiness in cell therapy manufacturing. The company said the expanded Board brings CDMO operations, commercialization, strategy, and financial expertise as it expands GMP capacity at its Princeton, NJ campus and partners with GC Corporation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Cue Health (Nasdaq: HLTH), a healthcare technology company, has filed for Chapter 7 bankruptcy in the District of Delaware, aiming to wind down its business. Despite efforts to reduce costs and find additional financing or strategic transactions, the Board of Directors, after thorough review and consultation, determined that filing for Chapter 7 was in the best interest of stakeholders. A bankruptcy trustee will be appointed to manage the liquidation of assets to pay creditors. Cue Health expressed gratitude to its employees, customers, and vendors for their contributions and partnerships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-39.51%
Tags
none
-
Rhea-AI Summary

Cue Health (Nasdaq: HLTH) has received a warning letter from the FDA regarding its Emergency Use Authorized (EUA) COVID-19 test. The healthcare technology company is currently evaluating the letter and determining an appropriate response. Further details will be provided in the coming days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.94%
Tags
Rhea-AI Summary

Cue Health Inc. (HLTH) is set to release its first quarter 2024 financial results on May 13, 2024, without hosting a conference call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.85%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.44%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.14%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.9%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags

FAQ

What is the current stock price of Cue Health (HLTH)?

The current stock price of Cue Health (HLTH) is $0.0434 as of February 7, 2025.

What is the market cap of Cue Health (HLTH)?

The market cap of Cue Health (HLTH) is approximately 6.9M.